21st Asia Pacific Diabetes Conference
Conference Series invites the worldwide global audience and presenters to participate at the 21st Asia Pacific Diabetes Conference which is to be held in Osaka, Japan during March 27-28, 2019.
Special interest and theme of the conference is “Lifestyle modifications and Management strategies for the prevention of diabetes”.
Diabetes is a disease in which the body is unable to properly use and store glucose (a form of sugar). Glucose backs up in the bloodstream — causing one’s blood glucose (sometimes referred to as blood sugar) to rise too high.
There are two major types of diabetes. In type 1 (formerly called juvenile-onset or insulin-dependent) diabetes, the body completely stops producing any insulin, a hormone that enables the body to use glucose found in foods for energy. People with type 1 diabetes must take daily insulin injections to survive. This form of diabetes usually develops in children or young adults, but can occur at any age. Type 2 (formerly called adult-onset or non-insulin-dependent) diabetes results when the body doesn’t produce enough insulin and/or is unable to use insulin properly (insulin resistance). This form of diabetes usually occurs in people who are over 40, overweight, and have a family history of diabetes, although today it is increasingly occurring in younger people, particularly adolescents.
Diabetes Asia Pacific 2019 aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. The meeting gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.This conference is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetes Asia Pacific 2019 is where the future of management and novel therapeutics for the disease intersects.
Why to attend?
Diabetes Asia Pacific 2019 highlights the theme “Lifestyle modifications and Management strategies for the prevention of diabetes” Which emphasis on the latest advancements in prevention and treatment cure of various metabolic diseases which may be due to diabetic and endocrine complications and provides robust discussions on methods and strategies related to diagnosis, prevention and management of metabolic disorders as well as explore new ideas and concepts for treatment of Endocrine Complications..
Physical trainer or Exercise physiologist
Track 1: Diabetes Diagnostics and Therapeutics
The incidence rate of diabetes is exceptionally high across the globe, fuelled by reducing physical activities and unhealthy diet. According to IMARC’s report, compared to Type-1 diabetes, Type-2 diabetes represents the more prevalent type, accounting for the majority of all diagnosed diabetes cases. Urban areas dominate rural areas in the number of diabetes patients and females presently account for the majority of the total diabetes patients. Despite the general down climate of the economy and healthcare, there has been great progress in the advancement of diabetes knowledge, treatment and prevention in recent years. This progress continues of a daily basis, with scientific advances being announced at an exponential rate. New therapeutic products are being introduced regularly and the pipeline is now full of new diabetes therapeutics in development. Never before, in the history of medicine, has the outlook for diabetes treatment and prevention looked so promising. The diabetes drugs segment dominated the endocrinology drugs market and accounted for more than 86% of the market share during 2015. At an annual growth rate (CAGR) of 4.4%, from 2016 to 2021, World diabetes market projected to reach $155 billion by 2021 from $125 billion. Follow Endocrinology Conferences and Diabetes Conferences for more updates.
Glucose absorption inhibitors(Sodium–Glucose Co-Transporter (SGLT-1 and 2) Inhibitors)
Glucagon-Like Peptide-1 (GLP-1) analogues (Lixisenatide)
Dipeptidyl Peptidase-IV (DPP IV) Inhibitors
Novel lyophilized hydrogel patches (Convenient insulin administration)
Insulin analogues & Insulin pumps
Track 2: Genetics and Gene Regulation
Diabetes constitutes a major public health problem. Although substantial progress has been made in defining the genetics of metabolic syndrome risk for specific subtypes of diabetes the majority of genetic risk of diabetes remain unresolved. This review focuses on the current knowledge of the genetic basis of diabetes and its complications, specifically diabetic nephropathy (DN), recent advances in genetics of diabetes, diabetes in ethnic groups, genetic lifestyle interactions and understanding the genetics of Diabetes. Ultimately, identification of genes that contribute to risk of diabetes and its complications will allow identification of patients who have diabetes and are at risk and targeted treatment/interventional strategies.
Track 3: Risk Factors and Related Diseases of Diabetes
Diabetes is always accompanied by a number of serious health issues. Consistent increase in blood glucose levels can lead to serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease like diabetic cardiomyopathy being one of the major risk factor, blindness, kidney failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina in the patients with diabetes adding as the most vulnerable risk for the patient. Maintaining blood glucose levels, blood pressure, diabetic gastro paresis which has been reported to have the main cause as Diabetes Mellitus and cholesterol at or close to normal can help delay or prevent diabetes complications.
Unexplained weight loss
Track 4: Pathophysiology Of Endocrine Glands And Hormones
Endocrine disorders can be classified according to the intensity of hormonal activity and according to the origin of endocrine disorder. From the intensity of hormonal activity of endocrine gland we can distinguish hyper function of endocrine gland, which is characterized by increased secretion of its hormone as well as by increased concentration of this hormone in circulating blood. If endocrine gland produces several kinds of hormones the symptoms resulting from hyper production or hypo production of more kinds of hormones may develop, respectively, at the same time the symptoms of hyper function resulting from overproduction of one kind of hormones and the symptoms of hypo function due to a deficiency of other kind of hormones can develop. Refunction of endocrine gland, which is in the time of medical examination characterized by normal secretion of its hormone as well as by normal concentration of this hormone in circulating blood. Endocrine disease results when a gland produces too much or too little of an endocrine hormone called as hormone imbalance.
Hormones and diabetes complications
Thyroid and thymus
Thyroid and thymus
Pituitary and pineal glands
Pituitary and pineal glands
Track 5: Diabetic Surgeries
Diabetes mellitus type 2 is an epidemic health problem, affecting more than 150 million people worldwide. This number is expected to double in the first decades of the third millennium. Recently, evidence for reduction of complications of type 2 diabetes with tight control of hyperglycaemia has been reported, but current therapies, including diet, exercise, behaviour modification, oral hypoglycaemic agents, and insulin, rarely return patients to euglycemia. Morbid obesity, in which patients exceed their ideal weight by at least 100 lb or are more than 200% of ideal body weight, is a condition with high mortality and morbidity because of its association with severe comorbid diseases such as hypertension, diabetes, hyperlipidaemia, and cardiopulmonary failure. In these patients, surgery represents the most effective therapy in that it achieves significant and durable weight loss as well as resolution or amelioration of comorbidities. Current indications for surgery in morbidly obese patients include body mass index (BMI) greater than 40 or greater than 35 if comorbidities are present.
Track 6: Clinical Research And Case Studies
A clinical trial is an approach to precisely test another Medic*tion or gadget in patients before it is endorsed by the FDA to be utilized in public. Clinical trials are an important and critical step in our having the capacity to have new medications for diabetes and other varied conditions. A case study is a methodology and a strategy that investigates a phenomenon with its real-life context. Case studies and clinical trials are used to develop or assess the quality of the medications being developed.
Clinical diagnosis and laboratory tests
Diabetes, Prediabetes and Metabolic Syndrome
Clinical trials on animal models
Novel research and treatment strategies on diabetes
Clinical case reports and clinical endocrinology practices
Novel Paradigms in Diabetic Complications
Clinical presentation and diagnosis of diabetes mellitus in adults
Track 7: Diabetic Nutrition & Physical Fitness
Diet and physical fitness are imperative parts of a sound way of life when you have diabetes. Alongside different advantages, following a healthy balanced diet and being dynamic can enable you to keep your blood glucose level in your objective range. To deal with your blood glucose, you must adjust with what you eat and drink along with physical movement and medications. The quantity and quality of food that you eat, and when you eat are extremely vital in keeping your blood glucose level in the range that your healthcare professional suggests.
Exercise for diabetics
Diet for Diabetics
Nutrition for Diabetics
Protein intake and Diabetes
Food combinations and diabetes
Lifestyle Intervention and Diabetes Prevention
Track 8 : Gestational diabetes
Gestational diabetes is diabetes that occurs during pregnancy in women. Gestational diabetes occurs in about 4% of all pregnancies. It is usually diagnosed at any stages of pregnancy but is more common in the second half and occurs in women who have no prior history of diabetes. In most cases Gestational diabetes is picked up when blood sugar level is tested during screening. Some women may develop symptoms if their blood sugar level becomes too high. This may lead to difficulties during the delivery and increases the chances of needing a caesarean section. Follow Diabetes Conferences for more details
Genetics of Diabetes
Etiology and pathogenesis
Monitoring fatal growth and well-being
Track 9 : Emerging Focus in Diabetes Research
Diabetes is a common chronic disease that imposes considerable demands on the individual healthcare system. People with diabetes have a higher rate of cardiovascular disease than those without diabetes and are at increased risk for kidney failure, lower limb amputation and blindness. Obesity is a significant risk factor for diabetes and the prevalence of obesity in children and adults has dramatically increased in the past four decades. Diabetic dyslipidaemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidaemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles. In order to investigate the bioinformatics tools and methodologies used to in diabetes research, at first, this was difficult to do because it did not have a preconceived idea about how the research would be organized and how bioinformatics tools would be described or identified in the research. To get started, we ran several cursory searches using basic search terms such as bioinformatics and diabetes (research) through several databases to see what types of articles were returned.
Diabetes and cancer
Type 1 Diabetes
Type 2 Diabetes
Track 10 :Stem Cell treatment for Type 2 Diabetes
In every of these cases, using one's own stem cells will facilitate the exocrine gland regenerate and boost its ability to produce insulin. Procedure continues to achieve success, with patients experiencing health advantages even six months after stem cell diabetes treatment. repeated applications of adipose stem cells is that the most effective treatment for diabetes type two, providing an open window to create dietary changes, supplementation and exercise much more effective for long-term management of blood glucose. Adult stem cells, undifferentiated and adaptable, area unit ready to transform into the cells of innumerable organs and structures inside the body.
Swiss Medical Clinic has developed the Adult autologous stem cell medical care program to treat a range of conditions. Throughout stem cell treatment a patient receives 200 – 300 million stem cells. The number of restored cells not only covers daily losses, however exceeds them 1000 times. Thus, the reserve of the stem cells, much lost for the newest 15 – 20 years, is restored. When such active cell filling, organ gets rejuvenated and revived, because the new and active cells displace the previous and broken ones.
Stem Cell Therapy
Treatment of Diabetes
Embryonic Stem Cell Research
Type 1 Diabetes Beta Cells
Umbilical Stem Cells
Stem Cells and Diabetes
Track 11 :Endocrinology and Diabetes
Endocrinology is a perplexing investigation of the different hormones and their activities and disarranges in the body. Endocrine Glands are organs that make hormones. These are substances that control exercises in the body and effectively affect the digestion system, multiplication, nourishment retention and use, development and improvement and so on. Hormones likewise control the way a living being reacts to their environment and help by giving sufficient vitality to different capacities. Diabetes is brought about by diminished creation of insulin or by diminished capacity to utilize insulin. Insulin, the hormone delivered by the beta cells in the pancreas, permits (glucose) cells to have the capacity to utilize glucose. This hormone is fundamental for glucose to go from the blood to within the body cells. With deficient insulin, glucose develops in the circulatory system as opposed to going into the cells. The body can't utilize glucose for vitality in spite of the elevated amounts of glucose in the circulatory system. This causes the unreasonable thirst, pee, and appetite, which are the most widely recognized side effects of diabetes. The abundance sugar stays in the blood and is then evacuated by the kidneys. This sickness happens in a few structures, yet the most well-known are Type I Diabetes or Juvenile Onset Diabetes or Insulin-Dependent Diabetes Mellitus (IDDM), Type II or Non-Insulin Dependent Diabetes Mellitus (NIDDM), and Gestational.
Congenital adrenal hyperplasia (CAH)
Track 12 :Public Health Challenges Of Diabetes
Public health protects and promotes the health of the people where they live. Public health professionals aim to prevent people living in communities from falling ill and create awareness among them to encourage healthy atmosphere. Vaccinating children to avoid spread of disease, educating them in terms of risk factors and preventive measures, developing nutritional programs etc. are carried out by people in public health departments. They also shed light on why few communities of people are more prone to a disease than others.
Track 13 : Nanotechnology For Diabetes Treatment
Nanotechnology holds a great deal of promise for the world of medicine. It is likely that some of the first truly revolutionary changes noticeable in our everyday lives will be brought about by nanomedicine. the possibilities of nanomedicine include Nano formulations for efficient drug delivery, smart drugs which only activate when needed, engineered microbes which produce human hormones, and even "Nano robots", which would move autonomously around the body acting as a boost, or a replacement, for our immune system, red blood cells, or many other biological systems. Whilst many of these applications of nanotechnology as a long way off, there is a great deal of active research into medical technology - much of which is not very far-fetched. This article explores the way in which nanotechnology could be used to effectively treat, and possibly cure, diabetes - in particular Type 1 diabetes.
Applications of Nanotechnology for Diabetes Management
Monitoring Glucose Levels
Potential Long-Term Treatments or Cures for Diabetes
Nano porous Immunoisolation Devices
Track 14 : Diabetic Nephropathy
Diabetic Nephropathy is the chronic loss of functioning of the kidneys occurring in those with diabetes. This is also known as End-Stage Renal Disease (ESRD). Not everyone with diabetes has kidney failure, around 40% of people with diabetes can develop nephropathy. Usual symptom is frequent urination, urine usually doesn’t contain protein albumin, but in some cases your kidneys are not able to filter the protein out the way they should and then the problem is diagnosed as diabetic nephropathy
Pathophysiology of Diabetic Nephropathy
Complications of Diabetic Nephropathy
Track 15 : Type 1 Diabetes & Type 2 Diabetes
Type 1 diabetes is a serious type of condition. It is also known as insulin-dependent diabetes. It's occasionally called "adolescent" diabetes, since Type 1 diabetes occurs more often in kids and young people. However, it can occur at any age. It is an autoimmune disease because the body’s immune system attacks its own pancreas and destroys its islet cells. These cells are responsible for producing insulin and maintaining the blood sugar levels in the body. Without insulin, the high sugars in the blood can damage eyes, nerves, heart, kidneys and other parts of the body.
Type 2 diabetes is a common condition that causes the level of sugar (glucose) in the blood to become too high. It can cause symptoms like excessive thirst, needing to pee a lot and tiredness. It can also increase your risk of getting serious problems with your eyes, heart and nerves. It's a lifelong condition that can affect your everyday life. You may need to change your diet, take medicines and have regular check-ups. It's caused by problems with a chemical in the body (hormone) called insulin. It's often linked to being overweight or inactive, or having a family history of type 2 diabetes.
Track 16 :Thyroid Disorders
Thyroid malignancy is a metastatic tumour of the thyroid organ. It is similarly unprecedented contrasted with different tumours. Inside USA, it is figured that in 2016 near 64,000 new patients will be determined to have thyroid growth, contrasted with in excess of 240,000 patients with bosom malignancy and 135,000 patients with colorectal tumour. Be that as it may, less than 2,000 patients kick the bucket of thyroid tumour every year. In 2013 more than 630,000 patients were living with thyroid tumour inside USA. Ongoing epidemiological information from WHO recommends that there are in excess of 750 million cases all around with a thyroid issue. Expanding centre by government associations and private organizations like WHO and pharmaceutical organizations, to make consciousness of thyroid lack is fuelling the market development. Levothyroxine and Cytomel are the most offering drugs in the thyroid insufficiency treatment advertise. Take after Endocrinology Conferences and Diabetes Conferences for more updates.
Hormones and diabetes complications
Thyroid and thymus
Track 17: Endocrinology Disorders
The endocrine system is a system of organs that deliver and discharge hormones that assistance control numerous vital body capacities, including the body's capacity to change calories into vitality that forces cells and organs. The endocrine framework impacts how your heart pulsates, how your bones and tissues develop, even your capacity to make an infant. It assumes an indispensable part in regardless of whether you create diabetes, thyroid malady, development issue, sexual brokenness, and a large group of other hormone-related scatters.
Gestational Diabetes- Treatment and care
Hyperandrogenism in women
Endocrinology of fertility
Hormonal Changes and its effects
Track 18 : Advanced Technologies for the Treatment of Diabetes
The concept of 'new technologies' for type 1 diabetes and new discovery and advanced type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law', and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate. From the patient’s perspective, this is not only exciting but can lead to a sense of optimism. Technologies that today are growing commonplace. come under new therapeutic mechanisms of diabetes. Indeed, it could be argued that the major advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology. At the same time, not all new technologies succeed, regardless of their purported promise. Both type 1 diabetes patients and their healthcare providers will soon see a series of further advanced medical technologies used in hospital and new technologies and novel therapies in diabetes treatment whose basis is tied to the notion of improving the lives of those with the disease.
New Discoveries and Emerging Therapies for Type 1 Diabetes
New Discovery and Treatment for Type 2 Diabetes
New Therapeutic Mechanisms for Diabetes
Other advanced medical technologies used in hospitals
Exploring novel therapies in diabetes treatment
2019 Upcoming Soon
Day 1 July 16, 2018
Town Hall Room
09:30-10:00 Opening Ceremony
Title: A breakthrough in the management of neuro-ischemic diabetic foot ulcers
Emilio Galea, Urgo International, United Arab Emirates
Networking & Refreshments break 10:45-11:05@Foyer
Title: Features of vegetative regulation in patients with diabetes 2 type depending on the structure of
Irina Kurnikova, RUDN University, Russia
11:50-12:35 Title: Individualized diabetes care: the real world experience
Joseph M Pappachan , University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Lunch Break 12:35-13:35@Four Element Restaurant
Pre-Diabetes/Borderline Diabetes (Pre-cursor to Diabetes Mellitus) | Influence of genetics on Diabetes | Metabolic Syndrome
/ Syndrome X | Cellular and Molecular Endocrinology | Endocrine complications | Insulin- Important Pancreatic hormone |
Diabetic Kidney Disease (Diabetic Nephropathy) | Diabetic Eye Disease (Diabetic Retinopathy) | Complications of Diabetes
Session Chair: Irina Kurnikova, RUDN University, Russia
Session Co-Chair: Joseph M Pappachan , University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Title: Diabetic foot ulcer primary prevention in vietnam – A longitudinal evaluation of a theory based
foot care education intervention programme
Thi Phuong Lan Nguyen, Queensland University of Technology, Australia
Title: Self Monitoring of Blood Glucose in Gestational Diabetes Mellitus: Improvements in the remote
monitoring by the doctor
Ramakrishnan Santosh, Magna Centres For Obesity, Diabetes and Endocrinology, India
14:35-15:05 Title: Dyslipidaemia as a risk factor for Erectile dysfunction in Type 2 diabetes mellitus patients
Shahjada Selim, Bangabandhu Sheikh Mujib Medical University, Bangladesh
15:05-15:35 Title: Serum markers for Early Detection of Peripheral Vascular Disease In Diabetic Patients
Aditya Vedula, Sree Balaji Medical College, India
Title: Is any sex-specific difference in diabetes adverse effects on the outcomes of patients with
myocardial infarction? A cohort study in western Iran
Soraya Siabani, Kermanshah University of Medical Sciences, Iran
16:05-16:25 Title: Social Media: A well-being mechanism for diabetic patients
Komal Verma, Amity University Rajasthan, India
Networking & Refreshments break 16:25-16:55@Foyer
Day 2 July 17, 2018
09:30-10:15 Title: Using Math-Physics Medicine to Predict FPG for T2D
Gerald C. Hsu, eclaireMD Foundation, USA
Networking & Refreshments break 10:15-10:35@Foyer
Title: Antimicrobial sensitivity pattern of uropathogens in Diabetic patients with urinary tract infection at
Mohammad Saifuddin, Abdul Malek Ukil Medical College, Bangladesh
Complications of Diabetes| Diabetic Transplantations |Important Tests to Diagnose Diabetes|Management
of Diabetes|Diabetes Oral Medications/Anti-Diabetic Medications|Approaches and technologies for the
Treatment of Diabetes|New Diabetes Treatments-Enhanced blood flow|Endocrine system and metabolic
diseases|Adrenomyeloneuropathy- Rare Genetic Disease
Session Chair: Emilio Galea, Urgo International, Singapore
Session Co-Chair: Mohammad Saifuddin, Abdul Malek Ukil Medical College, Bangladesh
11:20-11:50 Title: Treatment pattern for Newley diagnosed Type 2 diabetes in Dubai
Mohamed Farghaly, Dubai Medical college, Dubai
11:50-12:20 Title: Using Math-Physics Medicine to Predict PPG for T2D
Gerald C. Hsu, eclaireMD Foundation, USA
12:20-12:50 Title: Nephroprotective effect of Dillenia indica L. in STZ-induced diabetic rats via inhibition of oxidative stress
Randhir Singh, M.M. University, India
Lunch Break 12:50-13:50@Four Element Restaurant
Poster Session 13:50-14:50
Title: Effect of Ketogenic Diet versus Low-Calorie Diet on Reducing HbA1C Level in Patients with Type 2
Diabetes Mellitus: an Evidence-based Case Report
Muhamad Shafiq Advani, Faculty of Medicine of Universitas Indonesia, Indonesia
DAP-02 Title: Presentation and outcome of acute renal failure in diabetic patients
Uttam Kumar Dey, BIRDEM General Hospital, Bangladesh
Title: Evidence-based case report: The risk of developing diabetes mellitus in adult patients infected with
Hepatitis C virus
Wicensius Parulian Hasudungan, Kalideres District Primary Health Care, Indonesia
Title: Using Gallic Acid to Alleviate Diabetes and Nonalcoholic Fatty Liver Disease Induced by High Fat Diet
and Streptozotocin: A Pharmacodynamics and Metabolomics Evaluation
Li-Heng Pao, Chang Gung University of Science and Technology, Taiwan
DAP-05 Title: Albumin-to-creatinine ratio in spot urine to diagnose diabetic nephropathy: an evidence-based report
Ihsan A Adriansyah, Faculty of Medicine of Universitas Indonesia, Indonesia
Title: A descriptive study on causes of hypoglycemic events with an assessment of knowledge and
awareness on hypoglycemia, in a diabetic population admitted with a hypoglycemic episode
Chathuranga Lakmal Fonseka, University of Ruhuna, Sri Lanka
DAP-07 Title: Novel prediction method for early detection of diabetes mellitus by questionnaire
Shinn-Ying Ho, National Chiao Tung University, Taiwan
DAP-08 Title: HbA1c in healthy Sudanese pregnant women in reference to body mass index
Marwan Ismail, Gulf Medical University, UAE
Title: A descriptive study on thyroid status in a group of patients with type 2 diabetes and its association to
glycemic control, cardiovascular markers, macro and micro-vascular complications
Dayakshi Abeyaratne, National Hospital of Sri Lanka, Sri Lanka
Awards & Closing Ceremony
Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorship
NO REFUNDS ALLOWED ON REGISTRATIONS
Prices may go up any time. Service fees included in pricing.
This event is brought to you by:
Conference Series - NewYorkEventsList